MCB vs NEJM Clinician (formerly NEJM Journal Watch)

NEJM Journal Watch rebranded to NEJM Clinician in November 2025. If you're searching for the old name, this is the same product under a new brand with updated pricing and a redesigned platform.

Both NEJM Clinician and The Monday Clinical Brief are journal digest products — but they are built on different editorial philosophies, cover specialties in different ways, and sit at very different price points. Here is an honest comparison.

In short: NEJM Clinician is one general-medicine subscription at £75 a year, with expert-picked commentary from named US editors. The Monday Clinical Brief is £20 a year for one specialty, plus £5 for each extra, and covers every new paper in that specialty's top five journals, with a UK focus. If you work in general medicine and want an editor's commentary, NEJM Clinician is strong. If you want complete, UK-relevant coverage of your own specialty at a fraction of the price, MCB is the better fit.

What changed with the rebrand

The rebrand from NEJM Journal Watch to NEJM Clinician in November 2025 brought three meaningful changes:

• New name and platform. The interface was redesigned, and broader clinical context was added to summaries.
• Price reduction. The old UK price was in the £150–£250 range. NEJM Clinician now costs £75 a year, or £7.50 a month, for a single subscription — a material reduction that makes it more competitive.
• Clearer positioning. The new name signals that this is a clinical tool, not a journal alert service.

The editorial model has not changed: named senior clinicians curate selected papers from across the major journals (not just NEJM) and add commentary.

What NEJM Clinician does well

Named-editor credibility. NEJM Clinician's editors are senior, credentialed clinicians in their fields. Their names are attached to their commentary. For readers who value knowing who is making curation decisions, this matters.

Cross-journal scope. Despite the NEJM name, editors summarise research from over 150 journals, by NEJM's own count — not just the mothership. Coverage is expert picks across the literature, not comprehensive.

Built for generalists. NEJM says the product focuses on the research of greatest interest to general practitioners: internal and family medicine, ambulatory and hospital care, paediatrics, and obstetrics and gynaecology. If that is your work, its selection is aimed at you.

Where NEJM Clinician falls short for UK doctors

American editorial voice. NEJM Clinician is produced in the US, for a largely US audience. References to UK-specific guidance — NICE recommendations, Royal College positions, NHS clinical pathways — are limited. The evidence is the same evidence, but the context is not the context UK clinicians work in.

Specialists get highlights, not their journals. NEJM Clinician covers other specialties through selected papers, which you can filter by topic. If you are a nephrologist, an anaesthetist or a palliative care doctor, you see what its editors judge most important, not your field's own journals in full. MCB covers 31 specialties, and each one gets every new paper from its top five journals.

One price, whatever your specialty. £75 a year buys the whole product, and there is nothing extra to buy. But a specialist pays the same £75 for a product aimed mainly at generalists. On MCB, one specialty is £20, and two or three are £25 or £30.

CPD integration is US-focused. CME credits are calibrated to the US system. UK revalidation portfolios and FourteenFish are not natively supported.

The editorial philosophy difference

This is the deeper distinction, and it matters more than price.

NEJM Clinician uses expert picks: editors read the literature and select the papers they think are most important. You see what the editorial board has decided to surface.

MCB uses systematic journal-level selection: every week, we surface every new paper from the five highest-impact journals in each of 31 specialties. You see a consistent, structured picture of what was published — not a curated selection of what one editor found interesting.

Neither philosophy is wrong. Expert picks give you commentary and context. Systematic selection gives you confidence that you haven't missed something because an editor made a different call.

The price comparison

For one specialty, MCB costs less than a third as much, and covers that specialty's top journals in full. The comparison turns on whether named-editor commentary across general medicine justifies the premium for your work.

Who should choose which

Choose NEJM Clinician if: your work is general medicine, you value named senior-editor commentary, and the £75 price point is comfortable. The editorial credibility is genuine.

Choose MCB if: you want UK-specific context, complete coverage of your own specialty's journals, a lower price point, or you work across more than one specialty. At £20 for your specialty and £5 for each one you add, the maths is straightforward.

Use both if: you work in general medicine and want the editorial commentary layer on top of systematic weekly coverage. At a combined £95/year, this is still less than a single year of many premium alternatives.

NEJM Clinician's price and scope checked against NEJM's UK store and its own FAQ on 1 November 2026.

Start a four-week free trial of The Monday Clinical Brief — cancel any time before it renews.